Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
NCT06020495
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
260
Enrollment
OTHER
Sponsor class
Conditions
Hyponatremia
Interventions
DRUG:
DDAVP
DRUG:
Standard hyponatremia treatment
Sponsor
Assistance Publique - Hôpitaux de Paris